139 related articles for article (PubMed ID: 36802351)
1. Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients.
Berger T; Noble DJ; Yang Z; Shelley LE; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
Acta Oncol; 2023 Feb; 62(2):166-173. PubMed ID: 36802351
[TBL] [Abstract][Full Text] [Related]
2. Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features.
Berger T; Noble DJ; Shelley LEA; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
Phys Imaging Radiat Oncol; 2022 Oct; 24():95-101. PubMed ID: 36386445
[TBL] [Abstract][Full Text] [Related]
3. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
4. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
[TBL] [Abstract][Full Text] [Related]
5. Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.
van Dijk LV; Langendijk JA; Zhai TT; Vedelaar TA; Noordzij W; Steenbakkers RJHM; Sijtsema NM
Sci Rep; 2019 Aug; 9(1):12483. PubMed ID: 31462719
[TBL] [Abstract][Full Text] [Related]
6. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
[TBL] [Abstract][Full Text] [Related]
7. Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer.
Gjini M; Ahmed S; Kalnicki S; Tomé WA; Garg MK; Kabarriti R; Brodin NP
Acta Oncol; 2022 Sep; 61(9):1069-1074. PubMed ID: 35978529
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
[TBL] [Abstract][Full Text] [Related]
9. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
Rosen BS; Hawkins PG; Polan DF; Balter JM; Brock KK; Kamp JD; Lockhart CM; Eisbruch A; Mierzwa ML; Ten Haken RK; El Naqa I
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1319-1329. PubMed ID: 30003997
[TBL] [Abstract][Full Text] [Related]
10. Radiomics and dosiomics-based prediction of radiotherapy-induced xerostomia in head and neck cancer patients.
Abdollahi H; Dehesh T; Abdalvand N; Rahmim A
Int J Radiat Biol; 2023; 99(11):1669-1683. PubMed ID: 37171485
[TBL] [Abstract][Full Text] [Related]
11. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
13. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
15. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
16.
van Dijk LV; Noordzij W; Brouwer CL; Boellaard R; Burgerhof JGM; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
Radiother Oncol; 2018 Jan; 126(1):89-95. PubMed ID: 28951007
[TBL] [Abstract][Full Text] [Related]
17. Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y; Lee MT; Jameson MG; Chlap P; Keall P; Moses D; Lin P; Fowler A
Radiother Oncol; 2023 Sep; 186():109745. PubMed ID: 37330056
[TBL] [Abstract][Full Text] [Related]
18. Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
Wu H; Chen X; Yang X; Tao Y; Xia Y; Deng X; Zheng C; Robbins J; Schultz C; Li XA
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1308-1318. PubMed ID: 29891201
[TBL] [Abstract][Full Text] [Related]
19. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
Buettner F; Miah AB; Gulliford SL; Hall E; Harrington KJ; Webb S; Partridge M; Nutting CM
Radiother Oncol; 2012 Apr; 103(1):82-7. PubMed ID: 22444242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
